Intepirdine
id:
intepirdine-279-395173
title:
Intepirdine
text:
Intepirdine is a selective 5-HT6 receptor antagonist with potential cognition, memory, and learning-enhancing effects. It was under development by GlaxoSmithKline for the treatment of Alzheimer's disease and demonstrated some preliminary efficacy in phase II clinical trials. GSK chose not to continue development and sold the rights to Axovant Sciences for $5 million in December 2014. Results of a phase III clinical trial for the treatment of Alzheimer's disease were reported in September 2017. T
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Intepirdine
date created:
date modified:
2023-07-24T18:33:27Z
main entity:
{"identifier":"Q855449","url":"https://www.wikidata.org/entity/Q855449"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4a/Intepirdine.svg","width":105,"height":118}
fields total:
13
integrity:
15